Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7.
Hopkins BL, Nadler M, Skoko JJ, Bertomeu T, Pelosi A, Shafaei PM, Levine K, Schempf A, Pennarun B, Yang B, Datta D, Bucur O, Ndebele K, Oesterreich S, Yang D, Giulia Rizzo M, Khosravi-Far R, Neumann CA. Hopkins BL, et al. Among authors: yang d, yang b. Antioxid Redox Signal. 2018 Jan 1;28(1):62-77. doi: 10.1089/ars.2016.6871. Epub 2017 May 1. Antioxid Redox Signal. 2018. PMID: 28398822 Free PMC article.
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth.
Wilkinson AN, Chen R, Coleborn E, Neilson T, Le K, Bhavsar C, Wang Y, Atluri S, Irgam G, Wong K, Yang D, Steptoe R, Wu SY. Wilkinson AN, et al. Among authors: yang d. Cancer Immunol Immunother. 2024 Mar 30;73(5):80. doi: 10.1007/s00262-024-03674-w. Cancer Immunol Immunother. 2024. PMID: 38554167 Free PMC article.
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration.
Chen R, Coleborn E, Bhavsar C, Wang Y, Alim L, Wilkinson AN, Tran MA, Irgam G, Atluri S, Wong K, Shim JJ, Adityan S, Lee JS, Overwijk WW, Steptoe R, Yang D, Wu SY. Chen R, et al. Among authors: yang d. Mol Ther Oncolytics. 2023 Sep 13;31:100725. doi: 10.1016/j.omto.2023.09.001. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37781339 Free PMC article.
Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier.
Wan Z, Huang H, West RE 3rd, Zhang M, Zhang B, Cai X, Zhang Z, Luo Z, Chen Y, Zhang Y, Xie W, Yang D, Nolin TD, Wang J, Li S, Sun J. Wan Z, et al. Among authors: yang d. Mater Today (Kidlington). 2023 Jan-Feb;62:33-50. doi: 10.1016/j.mattod.2022.11.008. Epub 2022 Dec 8. Mater Today (Kidlington). 2023. PMID: 38239407 Free PMC article.
22,481 results
You have reached the last available page of results. Please see the User Guide for more information.